Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli

Gaurav et al. report a synergistic interaction between nalidixic acid and tetracycline against multi-drug resistant bacteria Acinetobacter baumannii and Escherichia coli. They find that this synergy does not work for clinical isolates susceptible to antibiotics, suggesting the potential application...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amit Gaurav, Varsha Gupta, Sandeep K. Shrivastava, Ranjana Pathania
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/5fa4ed4a3c9c4db28bbbc07074870b2a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5fa4ed4a3c9c4db28bbbc07074870b2a
record_format dspace
spelling oai:doaj.org-article:5fa4ed4a3c9c4db28bbbc07074870b2a2021-12-02T16:57:13ZMechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli10.1038/s42003-021-02074-52399-3642https://doaj.org/article/5fa4ed4a3c9c4db28bbbc07074870b2a2021-05-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-02074-5https://doaj.org/toc/2399-3642Gaurav et al. report a synergistic interaction between nalidixic acid and tetracycline against multi-drug resistant bacteria Acinetobacter baumannii and Escherichia coli. They find that this synergy does not work for clinical isolates susceptible to antibiotics, suggesting the potential application of nalidixic acid and tetracycline against the emergence of multi-drug resistant bacteria.Amit GauravVarsha GuptaSandeep K. ShrivastavaRanjana PathaniaNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Amit Gaurav
Varsha Gupta
Sandeep K. Shrivastava
Ranjana Pathania
Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
description Gaurav et al. report a synergistic interaction between nalidixic acid and tetracycline against multi-drug resistant bacteria Acinetobacter baumannii and Escherichia coli. They find that this synergy does not work for clinical isolates susceptible to antibiotics, suggesting the potential application of nalidixic acid and tetracycline against the emergence of multi-drug resistant bacteria.
format article
author Amit Gaurav
Varsha Gupta
Sandeep K. Shrivastava
Ranjana Pathania
author_facet Amit Gaurav
Varsha Gupta
Sandeep K. Shrivastava
Ranjana Pathania
author_sort Amit Gaurav
title Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
title_short Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
title_full Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
title_fullStr Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
title_full_unstemmed Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
title_sort mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of acinetobacter baumannii and escherichia coli
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5fa4ed4a3c9c4db28bbbc07074870b2a
work_keys_str_mv AT amitgaurav mechanisticinsightsintosynergybetweennalidixicacidandtetracyclineagainstclinicalisolatesofacinetobacterbaumanniiandescherichiacoli
AT varshagupta mechanisticinsightsintosynergybetweennalidixicacidandtetracyclineagainstclinicalisolatesofacinetobacterbaumanniiandescherichiacoli
AT sandeepkshrivastava mechanisticinsightsintosynergybetweennalidixicacidandtetracyclineagainstclinicalisolatesofacinetobacterbaumanniiandescherichiacoli
AT ranjanapathania mechanisticinsightsintosynergybetweennalidixicacidandtetracyclineagainstclinicalisolatesofacinetobacterbaumanniiandescherichiacoli
_version_ 1718382567454932992